BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,940,000 | -28.5% | 22,176 | -33.1% | 0.04% | -29.8% |
| Q2 2019 | $2,715,000 | +22.6% | 33,154 | +21.7% | 0.06% | +18.8% |
| Q1 2019 | $2,214,000 | +208.4% | 27,236 | +149.6% | 0.05% | +182.4% |
| Q4 2018 | $718,000 | -26.0% | 10,912 | -13.3% | 0.02% | -10.5% |
| Q3 2018 | $970,000 | +0.5% | 12,584 | -3.7% | 0.02% | -9.5% |
| Q2 2018 | $965,000 | -32.1% | 13,068 | -40.2% | 0.02% | -34.4% |
| Q1 2018 | $1,422,000 | -27.2% | 21,868 | -27.7% | 0.03% | -27.3% |
| Q4 2017 | $1,954,000 | -55.3% | 30,228 | -56.6% | 0.04% | -57.7% |
| Q3 2017 | $4,375,000 | -17.9% | 69,718 | -20.8% | 0.10% | -20.0% |
| Q2 2017 | $5,329,000 | +62.3% | 88,022 | +39.1% | 0.13% | +58.5% |
| Q1 2017 | $3,283,000 | +19.8% | 63,294 | +2.4% | 0.08% | +10.8% |
| Q4 2016 | $2,740,000 | – | 61,798 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |